1. Home
  2. AVIR vs NGS Comparison

AVIR vs NGS Comparison

Compare AVIR & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVIR
  • NGS
  • Stock Information
  • Founded
  • AVIR 2012
  • NGS 1998
  • Country
  • AVIR United States
  • NGS United States
  • Employees
  • AVIR N/A
  • NGS N/A
  • Industry
  • AVIR Medicinal Chemicals and Botanical Products
  • NGS Oilfield Services/Equipment
  • Sector
  • AVIR Health Care
  • NGS Energy
  • Exchange
  • AVIR Nasdaq
  • NGS Nasdaq
  • Market Cap
  • AVIR 284.6M
  • NGS 241.7M
  • IPO Year
  • AVIR 2020
  • NGS 2002
  • Fundamental
  • Price
  • AVIR $3.24
  • NGS $29.26
  • Analyst Decision
  • AVIR Hold
  • NGS Strong Buy
  • Analyst Count
  • AVIR 1
  • NGS 2
  • Target Price
  • AVIR $6.88
  • NGS $26.50
  • AVG Volume (30 Days)
  • AVIR 505.9K
  • NGS 83.5K
  • Earning Date
  • AVIR 02-26-2025
  • NGS 11-14-2024
  • Dividend Yield
  • AVIR N/A
  • NGS N/A
  • EPS Growth
  • AVIR N/A
  • NGS 605.21
  • EPS
  • AVIR N/A
  • NGS 1.28
  • Revenue
  • AVIR N/A
  • NGS $152,305,000.00
  • Revenue This Year
  • AVIR N/A
  • NGS $30.81
  • Revenue Next Year
  • AVIR N/A
  • NGS $13.48
  • P/E Ratio
  • AVIR N/A
  • NGS $23.02
  • Revenue Growth
  • AVIR N/A
  • NGS 41.72
  • 52 Week Low
  • AVIR $2.75
  • NGS $14.09
  • 52 Week High
  • AVIR $4.60
  • NGS $29.58
  • Technical
  • Relative Strength Index (RSI)
  • AVIR 47.81
  • NGS 66.72
  • Support Level
  • AVIR $3.11
  • NGS $27.15
  • Resistance Level
  • AVIR $3.49
  • NGS $28.40
  • Average True Range (ATR)
  • AVIR 0.14
  • NGS 1.26
  • MACD
  • AVIR -0.00
  • NGS 0.16
  • Stochastic Oscillator
  • AVIR 26.58
  • NGS 92.74

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

About NGS Natural Gas Services Group Inc.

Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.

Share on Social Networks: